{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T08:56:22Z","timestamp":1777971382984,"version":"3.51.4"},"reference-count":44,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,5,10]],"date-time":"2024-05-10T00:00:00Z","timestamp":1715299200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>\n                    None of the typhoid Vi Polysaccharide (ViPS) subunit vaccines incorporate adjuvants, and the immunogenicity of ViPS vaccines (e.g. Typbar TCV\n                    <jats:sup>\u00ae<\/jats:sup>\n                    and Typhim Vi\n                    <jats:sup>\u00ae<\/jats:sup>\n                    ) is in part due to associated TLR4 ligands such as endotoxin present in these vaccines. Since endotoxin content in vaccines is variable and kept very low due to inherent toxicity, it was hypothesized that incorporating a defined amount of a non-toxic TLR4-ligand such as monophosphoryl lipid A in ViPS vaccines would improve their immunogenicity. To test this hypothesis, a monophosphoryl lipid A-based adjuvant formulation named Turbo was developed. Admixing Turbo with Typbar TCV\n                    <jats:sup>\u00ae<\/jats:sup>\n                    (ViPS-conjugated to tetanus toxoid) increased the levels of anti-ViPS IgM, IgG1, IgG2b, IgG2a\/c, and IgG3 in inbred and outbred mice. In infant mice, a single immunization with Turbo adjuvanted Typbar TCV\n                    <jats:sup>\u00ae<\/jats:sup>\n                    resulted in a significantly increased and durable IgG response and improved the control of bacterial burden compared to mice immunized without Turbo. Similarly, when adjuvanted with Turbo, the antibody response and control of bacteremia were also improved in mice immunized with Typhim Vi\n                    <jats:sup>\u00ae<\/jats:sup>\n                    , an unconjugated vaccine. The immunogenicity of unconjugated ViPS is inefficient in young mice and is lost in adult mice when immunostimulatory ligands in ViPS are removed. Nevertheless, when adjuvanted with Turbo, poorly immunogenic ViPS induced a robust IgG response in young and adult mice, and this was observed even under antigen-limiting conditions. These data suggest that incorporation of Turbo as an adjuvant will make typhoid vaccines more immunogenic regardless of their intrinsic immunogenicity or conjugation status and maximize the efficacy across all ages.\n                  <\/jats:p>","DOI":"10.3389\/fimmu.2024.1383476","type":"journal-article","created":{"date-parts":[[2024,5,10]],"date-time":"2024-05-10T01:03:13Z","timestamp":1715302993000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["A TLR4 ligand-based adjuvant for promoting the immunogenicity of typhoid subunit vaccines"],"prefix":"10.3389","volume":"15","author":[{"given":"Kishore R.","family":"Alugupalli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2024,5,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciy846","article-title":"Progress in typhoid fever epidemiology","volume":"68","author":"Crump","year":"2019","journal-title":"Clin Infect Dis"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0006779","article-title":"A systematic review of antimicrobial resistance in Salmonella enterica serovar Typhi, the etiological agent of typhoid","volume":"12","author":"Britto","year":"2018","journal-title":"PloS Negl Trop Dis"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiab449","article-title":"Typhoid conjugate vaccines: advancing the research and public health agendas","volume":"224","author":"Birkhold","year":"2021","journal-title":"J Infect Dis"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1084\/jem.20201116","article-title":"Vi-specific serological correlates of protection for typhoid fever","volume":"218","author":"Jin","year":"2021","journal-title":"J Exp Med"},{"key":"B5","doi-asserted-by":"crossref","DOI":"10.1016\/B978-1-4160-3611-1.50038-6","volume-title":"Typhoid Fever Vaccine","author":"Levine","year":"2008"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0060583","article-title":"Head-to-head comparison of humoral immune responses to Vi capsular polysaccharide and Salmonella Typhi Ty21a typhoid vaccines\u2013a randomized trial","volume":"8","author":"Kantele","year":"2013","journal-title":"PloS One"},{"key":"B7","doi-asserted-by":"publisher","first-page":"5","DOI":"10.2165\/00063030-200115001-00002","article-title":"Comparative tolerability and immunogenicity of Typherix or Typhim Vi in healthy adults: 0, 12-month and 0, 24-month administration","author":"Lebacq","year":"2001","journal-title":"BioDrugs"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200104263441701","article-title":"The efficacy of a Salmonella typhi Vi conjugate vaccine in two-to-five-year-old children","volume":"344","author":"Lin","year":"2001","journal-title":"N Engl J Med"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(13)70241-X","article-title":"Immunogenicity and safety of the Vi-CRM197 conjugate vaccine against typhoid fever in adults, children, and infants in south and southeast Asia: results from two randomised, observer-blind, age de-escalation, phase 2 trials","volume":"14","author":"Bhutta","year":"2014","journal-title":"Lancet Infect Dis"},{"key":"B10","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1093\/cid\/civ295","article-title":"Safety and immunogenicity of a Vi polysaccharide-tetanus toxoid conjugate vaccine (Typbar-TCV) in healthy infants, children, and adults in typhoid endemic areas: a multicenter, 2-cohort, open-label, double-blind, randomized controlled phase 3 study","volume":"61","author":"Mohan","year":"2015","journal-title":"Clin Infect Dis"},{"key":"B11","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1186\/s12887-020-02375-4","article-title":"A novel Vi-diphtheria toxoid typhoid conjugate vaccine is safe and can induce immunogenicity in healthy Indonesian children 2-11 years: a phase II preliminary report","volume":"20","author":"Medise","year":"2020","journal-title":"BMC Pediatr"},{"key":"B12","doi-asserted-by":"publisher","first-page":"29","DOI":"10.4049\/immunohorizons.2300085","article-title":"TLR4 ligands in typhoid vi polysaccharide subunit vaccines contribute to immunogenicity","volume":"8","author":"Alugupalli","year":"2024","journal-title":"Immunohorizons"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2035916","article-title":"Safety and efficacy of a typhoid conjugate vaccine in Malawian children","volume":"385","author":"Patel","year":"2021","journal-title":"N Engl J Med"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/S2214-109X(21)00346-6","article-title":"Efficacy of typhoid conjugate vaccine in Nepal: final results of a phase 3, randomised, controlled trial","volume":"9","author":"Shakya","year":"2021","journal-title":"Lancet Glob Health"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)01124-7","article-title":"Protection by vaccination of children against typhoid fever with a Vi-tetanus toxoid conjugate vaccine in urban Bangladesh: a cluster-randomised trial","volume":"398","author":"Qadri","year":"2021","journal-title":"Lancet"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(13)70292-5","article-title":"A conjugate vaccine against typhoid fever","volume":"14","author":"Park","year":"2014","journal-title":"Lancet Infect Dis"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2005857117","article-title":"Short Vi-polysaccharide abrogates T-independent immune response and hyporesponsiveness elicited by long Vi-CRM(197) conjugate vaccine","volume":"117","author":"Micoli","year":"2020","journal-title":"Proc Natl Acad Sci U.S.A"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1101\/SQB.1989.054.01.003","article-title":"Approaching the asymptote? Evolution and revolution in immunology","author":"Janeway","year":"1989","journal-title":"Cold Spring Harb Symp Quant Biol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1146\/annurev.immunol.20.083001.084359","article-title":"Innate immune recognition","volume":"20","author":"Janeway","year":"2002","journal-title":"Annu Rev Immunol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2010.08.002","article-title":"TLR-based immune adjuvants","volume":"29","author":"Steinhagen","year":"2011","journal-title":"Vaccine"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1701348","article-title":"An unmutated igM response to the vi polysaccharide of salmonella typhi contributes to protective immunity in a murine model of typhoid","volume":"200","author":"Pandya","year":"2018","journal-title":"J Immunol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2013.08.037","article-title":"A novel method for purification of Vi capsular polysaccharide produced by Salmonella enterica subspecies enterica serovar Typhi","volume":"31","author":"Kothari","year":"2013","journal-title":"Vaccine"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.00232-13","article-title":"Loss of very-long O-antigen chains optimizes capsule-mediated immune evasion by Salmonella enterica serovar Typhi","volume":"4","author":"Crawford","year":"2013","journal-title":"MBio"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.4049\/immunohorizons.2200088","article-title":"The lack of natural igM increases susceptibility and impairs anti-vi polysaccharide igG responses in a mouse model of typhoid","volume":"6","author":"Alugupalli","year":"2022","journal-title":"Immunohorizons"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.00211-18","article-title":"Terminal Deoxynucleotidyl Transferase Is Not Required for Antibody Response to Polysaccharide Vaccines against Streptococcus pneumoniae and Salmonella enterica Serovar Typhi","volume":"86","author":"Belde","year":"2018","journal-title":"Infect Immun"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1800162","article-title":"IL-7 enables antibody responses to bacterial polysaccharides by promoting B cell receptor diversity","volume":"201","author":"Dickinson","year":"2018","journal-title":"J Immunol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.00115-14","article-title":"Serum bactericidal assays to evaluate typhoidal and nontyphoidal Salmonella vaccines","volume":"21","author":"Boyd","year":"2014","journal-title":"Clin Vaccine Immunol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.01571-06","article-title":"The capsule encoding the viaB locus reduces interleukin-17 expression and mucosal innate responses in the bovine intestinal mucosa during infection with Salmonella enterica serotype Typhi","volume":"75","author":"Raffatellu","year":"2007","journal-title":"Infect Immun"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.814088","article-title":"A mouse immunogenicity model for the evaluation of meningococcal conjugate vaccines","volume":"13","author":"Arunachalam","year":"2022","journal-title":"Front Immunol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2011.05.022","article-title":"Mouse models to assess the efficacy of non-typhoidal Salmonella vaccines: revisiting the role of host innate susceptibility and routes of challenge","volume":"29","author":"Simon","year":"2011","journal-title":"Vaccine"},{"key":"B31","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s12979-019-0164-9","article-title":"Immunosenescence and human vaccine immune responses","volume":"16","author":"Crooke","year":"2019","journal-title":"Immun Ageing"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1031924","article-title":"The adaptive immune system in early life: The shift makes it count","volume":"13","author":"Pieren","year":"2022","journal-title":"Front Immunol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1038\/s41598-023-27400-1","article-title":"Identification of collaborative cross mouse strains permissive to Salmonella enterica serovar Typhi infection","volume":"13","author":"Alugupalli","year":"2023","journal-title":"Sci Rep"},{"key":"B34","doi-asserted-by":"publisher","first-page":"2043103","DOI":"10.1080\/21645515.2022.2043103","article-title":"A multicenter, single-blind, randomized, phase-2\/3 study to evaluate immunogenicity and safety of a single intramuscular dose of biological E\u2019s Vi-capsular polysaccharide-CRM197 conjugate typhoid vaccine (TyphiBEV(TM)) in healthy infants, children, and adults in comparison with a licensed comparator","volume":"18","author":"Thuluva","year":"2022","journal-title":"Hum Vaccin Immunother"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1128\/jb.145.2.1010-1017.1981","article-title":"Genetic regulation of variable Vi antigen expression in a strain of Citrobacter freundii","volume":"145","author":"Snellings","year":"1981","journal-title":"J Bacteriol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1128\/iai.59.12.4555-4561.1991","article-title":"Relation between structure and immunologic properties of the Vi capsular polysaccharide","volume":"59","author":"Szu","year":"1991","journal-title":"Infect Immun"},{"key":"B37","doi-asserted-by":"publisher","first-page":"33924","DOI":"10.1038\/srep33924","article-title":"Decreased IL7Ralpha and TdT expression underlie the skewed immunoglobulin repertoire of human B-cell precursors from fetal origin","volume":"6","author":"Rother","year":"2016","journal-title":"Sci Rep"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1038\/ni1033","article-title":"Age-related changes in lymphocyte development and function","volume":"5","author":"Linton","year":"2004","journal-title":"Nat Immunol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"185ps188","DOI":"10.1126\/scitranslmed.3005624","article-title":"The gracefully aging immune system","volume":"5","author":"Boraschi","year":"2013","journal-title":"Sci Transl Med"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.165.3.1243","article-title":"Age-dependent alterations in the assembly of signal transduction complexes at the site of T cell\/APC interaction","volume":"165","author":"Tamir","year":"2000","journal-title":"J Immunol"},{"key":"B41","article-title":"Endotoxin content in Haemophilus influenzae type b vaccine","volume":"57","author":"Ochiai","year":"2004","journal-title":"Jpn J Infect Dis"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15071884","article-title":"Aluminum adjuvants-\u2019Back to the future\u2019","volume":"15","author":"Laera","year":"2023","journal-title":"Pharmaceutics"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1043109","article-title":"New-age vaccine adjuvants, their development, and future perspective","volume":"14","author":"Verma","year":"2023","journal-title":"Front Immunol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiy506","article-title":"An adjuvant that increases protective antibody responses to polysaccharide antigens and enables recall responses","volume":"219","author":"Phipps","year":"2019","journal-title":"J Infect Dis"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2024.1383476\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,10]],"date-time":"2024-05-10T01:03:15Z","timestamp":1715302995000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2024.1383476\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,10]]},"references-count":44,"alternative-id":["10.3389\/fimmu.2024.1383476"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2024.1383476","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2024.03.22.581918","asserted-by":"object"}]},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,10]]},"article-number":"1383476"}}